Literature DB >> 232696

Studies on antibody to hepatitis A virus in children and adults in London.

V Damjanovic, M Ross, W Brumfitt.   

Abstract

366 specimens of serum from children and adults without liver disease were screened for antibody to hepatitis A virus (anti-HAV) by means of radioimmunoassay. 56% were born in London, 26% came to London from various parts of the United Kingdom and the remainder (18%) from various parts of the world. The prevalence of antibody was related to increasing age, ranging from 7% in children under ten years of age to 77% in adults aged 50 years or more. The prevalence of anti-HAV was significantly higher in females, in the lower socio-economic class and in those not indigenous to London. In comparison to other urban populations such as those of the United States and Western Europe, the prevalence of anti-HAV was similar in terms of the overall prevalence and age distribution. By contrast, these findings were entirely different from the countries of Eastern Europe and the Middle East where the overall prevalence was higher but the anti-HAV was equal in all ages. Thus, the findings presented indicate that hepatitis A virus infection is common in London and also shows a clear relationship to advancing age, lower socioeconomic class and the country of origin.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 232696     DOI: 10.1007/bf01642145

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  30 in total

1.  [Antibodies against hepatitis A virus in soldiers of the Yugoslav People's Army - blood donors].

Authors:  P Mijusković; M Radović; V Damjanović; M Ross; D Durić; R Kaljalović
Journal:  Vojnosanit Pregl       Date:  1978 Nov-Dec       Impact factor: 0.168

2.  A specific complement-fixation test for human hepatitis a employing CR326 virus antigen. Diagnosis and epidemiology.

Authors:  P J Provost; O L Ittensohn; V M Villarejos; M R Hilleman
Journal:  Proc Soc Exp Biol Med       Date:  1975-04

3.  The prevalence of antibody to hepatitis A virus in two populations in Victoria.

Authors:  N I Lehmann; I D Gust
Journal:  Med J Aust       Date:  1977-11-26       Impact factor: 7.738

4.  Preliminary serologic studies of antibody to hepatitis A virus in populations in the United States.

Authors:  J E Maynard; D W Bradley; C L Hornbeck; R M Fields; I L Doto; F B Hollinger
Journal:  J Infect Dis       Date:  1976-11       Impact factor: 5.226

5.  Decrease in incidence of hepatitis A infections in Germany.

Authors:  G Frösner; H Willers; R Müller; D Schenzle; F Deinhardt; W Höpken
Journal:  Infection       Date:  1978       Impact factor: 3.553

6.  Review of infectivity studies in nonhuman primates with virus-like particles associated with MS-1 hepatitis.

Authors:  J E Maynard; D Lorenz; D W Bradley; S M Feinstone; D H Krushak; L F Barker; R H Purcell
Journal:  Am J Med Sci       Date:  1975 Jul-Aug       Impact factor: 2.378

7.  Hepatitis A: report of a common-source outbreak with recovery of a possible etiologic agent. II. Laboratory studies.

Authors:  C R Gravelle; C L Hornbeck; J E Maynard; C A Schable; E H Cook; D W Bradley
Journal:  J Infect Dis       Date:  1975-02       Impact factor: 5.226

8.  A prospective study of acute viral hepatitis with particular reference to hepatitis A.

Authors:  S A Locarnini; I D Gust; A A Ferris; A C Stott; M L Wong
Journal:  Bull World Health Organ       Date:  1976       Impact factor: 9.408

9.  Seroepidemiology of infection with hepatitis A and B viruses in an isolated Pacific population.

Authors:  I D Gust; N I Lehmann; M Dimitrakakis; P Zimmet
Journal:  J Infect Dis       Date:  1979-05       Impact factor: 5.226

10.  Non-B hepatitis in Melbourne: a serological study of hepatitis A virus infection.

Authors:  I D Gust; J L Dienstag; R H Purcell; C R Lucas
Journal:  Br Med J       Date:  1977-01-22
View more
  3 in total

1.  Hepatitis A virus antibodies in Belgium: relationship between prevalence and age.

Authors:  R Vranckx; L Muylle
Journal:  Infection       Date:  1990 Nov-Dec       Impact factor: 3.553

2.  Clinical, biochemical, serological, histological and ultrastructural features of liver disease in drug abusers.

Authors:  I V Weller; D Cohn; A Sierralta; M Mitcheson; M G Ross; L Montano; P Scheuer; H C Thomas
Journal:  Gut       Date:  1984-04       Impact factor: 23.059

3.  Changing epidemiological characteristics of acute viral hepatitis in Greece.

Authors:  G Papaevangelou; A Roumeliotou-Karayannis; P Contoyannis
Journal:  Infection       Date:  1982-01       Impact factor: 3.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.